Etoricoxib, Promotion Season Now in Store and Free Sample for Testing with Factory Price
Chemical Name: Etoricoxib
CAS No.: 202409-33-4
Molecular Fomula: C18H15ClN2O2S
Molecular weight: 358.84
Appearance: White Powder
Sample: Available
Send Inquiry
Download Quotation
Description of Algix
Etoricoxib (Arcoxia) is a selective COX-2 inhibitor from Merck & Co. Currently it is approved in more than 80 countries worldwide but not in the US, where the Food and Drug Administration (FDA) has required additional safety and efficacy data for etoricoxib before it will issue approval.
Basic Info of Etoricoxib
Basic Info
Numbering system
Properties
Safety Info
Basic Info
Chemical Name | etoricoxib |
CAS No. | 202409-33-4 |
Molecular Formula | C18H15ClN2O2S |
Molecular Weight | 358.84200 |
PSA | 68.30000 |
LogP | 5.25670 |
Numbering system
MDL number | MFCD06797512 |
Properties
Appearance & Physical State | off-white powder |
Density | 1.298 g/cm3 |
Boiling Point | 510ºC at 760 mmHg |
Melting Point | 134-135ºC |
Flash Point | 262.2ºC |
Refractive Index | 1.6 |
Vapor Pressure | 5.17E-10mmHg at 25°C |
Safety Info
Safety Statements | S26; S36 |
HS Code | 2933399090 |
WGK Germany | 3 |
Risk Statements | R36/37/38 |
Hazard Codes | Xi |
What is Algix?
- With the progress of science and technology and the development of society, chemical products have invariably permeated our daily lives, in medicine, food, cosmetics, electronics, industry, and other areas, becoming an essential part of our lives. One such product is Etoricoxib which has developed particularly rapidly in recent years. Do you know about Etoricoxib?
- The official answer: Etoricoxib is used to treat signs and symptoms in the acute and chronic phases of osteoarthritis and to treat acute gouty arthritis, and the prescription choice of cyclooxygenase-2 inhibitors should give a thorough assessment of individual patient risk.
What’s the application of Algix?
The difference in the incidence of thrombotic cardiovascular events between this product and diclofenac was not significant, while the cumulative incidence of clinically confirmed gastrointestinal perforation, ulceration, and bleeding was significantly lower in the etoricoxib group than in the diclofenac group. The incidence of gastrointestinal adverse events was 50% lower than that of diclofenac sodium. The incidence of adverse reactions such as gastrointestinal symptoms Chemicalbook (nausea, vomiting, abdominal pain or discomfort, diarrhoea), chest tightness and ankle oedema during drug administration.
Conclusion
Sincere to the customer and in good faith of quality is our forever followed motto. It’s the basement to be a human and do business. We take all responsibility for our products and service sincerely. We are a company integrating R&D, production, and sales. The design, research, and development of pharmaceutical intermediates including more than 330 kinds of pharmaceutical intermediates such as Anti-infectives, Cardiovascular and Cerebrovascular Systems, Digestive System, Santi-tumor, Nervous System, Geriatric Drugs, and Gynecological Drugs. At the same time, we have more than 4,000 factories in strategic cooperation with nearly 50,000 chemical products, so we can provide you with a one-stop purchasing service, which greatly saves customers’ procurement costs and time.
Keywords of Algix
Etoricoxib, 202409-33-4, buy Algix, Algixsupplier, purchase Algix, Algixcost, Algixmanufacturer, order Algix, high purity Algix.